CD8A and neoplasm: ,2 During tumorigenesis, the interaction of co-inhibitory checkpoint receptors with their ligands on tumor and stromal cells accounts for the inhibition/exhaustion of tumor-associated CD8 T cells and tumor cells’ avoidance of immune destruction.3